The France immunoassay market, valued at USD 1,106.33 million in 2024, is projected to reach USD 1,602.94 million by 2034, growing at a compound annual growth rate (CAGR) of 3.7% over the forecast period. Increasing healthcare demands, particularly in chronic disease diagnostics and point-of-care testing, are expected to fuel steady market expansion over the next...